{"title":"Journal of Generic Medicine – Editorial June 2022","authors":"B. Tempest","doi":"10.1177/17411343221098791","DOIUrl":null,"url":null,"abstract":"The fall in ANDA generic medicines approvals in the USA that was seen in 2020 has continued into 2021. West Virginia University has bought a 23-acre generic medicines manufacturing plant in the USA which employed 1400 workers for $1 from Viatris. The Indian generic companies ranked first with 42% of all USA ANDA approvals and the Chinese companies came in third with 10%. [Extracted from the article] Copyright of Journal of Generic Medicines is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)","PeriodicalId":15914,"journal":{"name":"Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector","volume":"4 1","pages":"71 - 71"},"PeriodicalIF":0.0000,"publicationDate":"2022-05-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Generic Medicines: The Business Journal for the Generic Medicines Sector","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1177/17411343221098791","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
The fall in ANDA generic medicines approvals in the USA that was seen in 2020 has continued into 2021. West Virginia University has bought a 23-acre generic medicines manufacturing plant in the USA which employed 1400 workers for $1 from Viatris. The Indian generic companies ranked first with 42% of all USA ANDA approvals and the Chinese companies came in third with 10%. [Extracted from the article] Copyright of Journal of Generic Medicines is the property of Sage Publications Inc. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)